Observational studyMedicine2025
Hematological abnormalities and associated factors among adult HIV/AIDS patients on antiretroviral therapy at Hiwot Fana Comprehensive Specialized Hospital: A cross sectional study.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Immune and hematologic alterations associated with CD4AIDS research and therapy · 2026Article
- Clinico-microbiological investigation of factors contributing to suboptimal viral suppression among HIV/AIDS patients on sustained antiretroviral treatment in the upper east region of Ghana.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hematological abnormalities are common in individuals with human immunodeficiency virus (HIV) infection and can have significant clinical implications. These abnormalities can affect various components of the blood, including red blood cells, white blood cells, and platelets. However, screening and follow up of HIV positive patients for these abnormalities is not well reported in Ethiopia, specifically in Harar. Therefore, this study is aimed to determine prevalence of hematological abnormalities and associated factors among Adult HIV infected patients on antiretroviral therapy at the Antiretroviral clinic of Hiwot Fana Comprehensive Specialized Hospital, Eastern Ethiopia, from September 2, October 30, 2024. A hospital based cross-sectional study was conducted by involving 300 study participants using convenient sampling technique. Data related to socio-demographic, clinical and dietary variables were collected using structured questionnaires. All phase of quality assurance was maintained. Four milliliters of venous blood were collected from each study participant and complete blood count was determined using unicell DxH 800 hematological analyzer. Logistic regression was conducted to assess the association between hematological abnormalities and independent variables. P < .05 was considered statically significant. The overall prevalence of hematological abnormality among HIV/acquired immunodeficiency syndrome (AIDS) patients were 26.33%. Whereas prevalence of anemia, leucopenia and thrombocytopenia in this study were 16.7%, 4.33%, and 5.3%, respectively. HIV/AIDS patients with underweight BMI (AOR = 3.94, 95% CI: 1.08-14.36), male gender (AOR = 2.71, 95% CI: 1.35-5.44), HIV patients who have lived with HIV infections for more than 12 years (AOR = 2.77, 95% CI: 1.43-5.39) and HIV patients who have a monthly income of 1500 to 5000 Ethiopian birrs (AOR = 4.38, 95% CI: 1.19-16.1) were significantly associated with anemia. hematological abnormality was found to be a moderate public health problem among anti-retroviral therapy attendants in the current study area. Also, early detection and intervention among, males, patients having body mass index < 18.5 kg/m2, patients having low monthly income and patients who lived with HIV for more than 12 years is vital to reduce the magnitude of anemia and its consequences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.